MMS developed a simulation-driven framework to help sponsors and regulators evaluate immature overall survival data systematically using advanced analytics and KerusCloud.
Published
Signal category
Products & Services
Quote
“MMS developed a simulation-driven framework to help sponsors and regulators evaluate immature OS data more systematically. By leveraging advanced analytics and KerusCloud®”
— MMS team
Company
MMS
The difference is in the data.
- Industry
- Pharmaceutical Manufacturing
- Location
- Canton, US
- Company size
- 3,208 employees
MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, a 20-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner. With a global footprint across four continents, MMS maintains an industry-leading customer satisfaction rating. For more information, visit www.mmsholdings.com
Founded 2006